dc.creator | Alcaraz-Iborra M. | |
dc.creator | Carvajal F. | |
dc.creator | Lerma-Cabrera J.M. | |
dc.creator | Valor L.M. | |
dc.creator | Cubero I. | |
dc.date.accessioned | 2020-09-02T22:11:04Z | |
dc.date.accessioned | 2022-11-08T20:24:18Z | |
dc.date.available | 2020-09-02T22:11:04Z | |
dc.date.available | 2022-11-08T20:24:18Z | |
dc.date.created | 2020-09-02T22:11:04Z | |
dc.date.issued | 2014 | |
dc.identifier | 272, , 93-99 | |
dc.identifier | 01664328 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3507 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145217 | |
dc.language | en | |
dc.publisher | Elsevier | |
dc.subject | Binge-like consumption | |
dc.subject | Drinking in the Dark (DID) | |
dc.subject | Orexins | |
dc.subject | Palatable substances | |
dc.subject | 1 (2 methyl 6 benzoxazolyl) 3 (1,5 naphthyridin 4 yl)urea | |
dc.subject | messenger RNA | |
dc.subject | orexin | |
dc.subject | orexin 1 receptor | |
dc.subject | saccharin | |
dc.subject | sucrose | |
dc.subject | 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea | |
dc.subject | agents interacting with transmitter, hormone or drug receptors | |
dc.subject | benzoxazole derivative | |
dc.subject | drinking water | |
dc.subject | messenger RNA | |
dc.subject | mitochondrial protein | |
dc.subject | neuropeptide | |
dc.subject | nuclear protein | |
dc.subject | orexins | |
dc.subject | Oxr1 protein, mouse | |
dc.subject | saccharin | |
dc.subject | signal peptide | |
dc.subject | sugar intake | |
dc.subject | urea | |
dc.subject | adult | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | article | |
dc.subject | binge eating disorder | |
dc.subject | controlled study | |
dc.subject | dose response | |
dc.subject | drinking behavior | |
dc.subject | drug dose comparison | |
dc.subject | drug effect | |
dc.subject | gene expression | |
dc.subject | lateral hypothalamus | |
dc.subject | locomotion | |
dc.subject | male | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | signal transduction | |
dc.subject | administration and dosage | |
dc.subject | analogs and derivatives | |
dc.subject | animal | |
dc.subject | antagonists and inhibitors | |
dc.subject | bulimia | |
dc.subject | C57BL mouse | |
dc.subject | caloric intake | |
dc.subject | drug effects | |
dc.subject | metabolism | |
dc.subject | motor activity | |
dc.subject | physiology | |
dc.subject | sugar intake | |
dc.subject | Animals | |
dc.subject | Benzoxazoles | |
dc.subject | Bulimia | |
dc.subject | Dietary Sucrose | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Drinking Behavior | |
dc.subject | Drinking Water | |
dc.subject | Energy Intake | |
dc.subject | Hypothalamic Area, Lateral | |
dc.subject | Intracellular Signaling Peptides and Proteins | |
dc.subject | Male | |
dc.subject | Mice, Inbred C57BL | |
dc.subject | Mitochondrial Proteins | |
dc.subject | Motor Activity | |
dc.subject | Neuropeptides | |
dc.subject | Neurotransmitter Agents | |
dc.subject | Nuclear Proteins | |
dc.subject | RNA, Messenger | |
dc.subject | Saccharin | |
dc.subject | Urea | |
dc.title | Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement | |
dc.type | Article | |